Niacinamide supports the cellular machinery that processes those calories, enhances mitochondrial efficiency, and may reduce inflammation in adipose tissue
Primary Handling Editor: Jean Nakhle, in collaboration with the Nature Metabolism team
Companies are racing to develop alternatives to injectable diabetes and weight loss drugs Injectable peptide drugs targeting the glucagon-like peptide 1 (GLP-1) receptor have had massive impact on approaches to treating diabetes and obesity, bringing huge revenue boosts to makers Novo Nordisk and Eli Lilly
This blog aims to delve into the origins of GLP-1, its mechanisms, common drug names, the associated benefits and risks, and the weight loss statistics with GLP-1 use, with insights from experts such as Dr
Retatrutide may also cause more pronounced heart rate increases